评估怀孕中期的Gas6水平作为妊娠糖尿病和分娩结果的预测值
Yeşim Cıvıl Ürkmez1, Neşet Gümüşburun2, Sebati Sinan Ürkmez3
1University of Health Sciences Türkiye, Samsun Training and Research Hospital, Clinic of Medical Biochemistry, Samsun, Türkiye.
Turkish journal of obstetrics and gynecology
|October 27, 2025
概括
在怀孕早期增加的母体血清增长停止特异性6 (Gas6) 可能预测妊娠期糖尿病 (GDM) 风险. 较高的Gas6水平与GDM,BMI增加和新生儿不良结果有关.
科学领域:
- 生殖医学 生殖医学
- 内分泌学 在内分泌学.
- 生物标志物发现发现
背景情况:
- 孕期糖尿病 (GDM) 影响母亲和胎儿的健康.
- 早期发现GDM风险对于及时干预至关重要.
- 增长阻断特异性6 (Gas6) 是一种蛋白质,在代谢和血管健康方面具有潜在的作用.
研究的目的:
- 调查第二个三个月的母体血清Gas6水平与GDM发育之间的关联.
- 探索Gas6与母亲特征 (BMI,葡萄糖耐受性) 之间的关系.
- 评估Gas6水平与母亲和新生儿结局之间的联系.
主要方法:
- 对173名孕妇 (89名GDM,84名对照) 的前性研究.
- 使用ELISA测量血清Gas6水平在怀孕的第二个三个月.
- 对Gas6水平与BMI,口服葡萄糖耐受性测试 (OGTT) 结果以及新生儿数据的统计分析.
主要成果:
- 在患有GDM的女性中,Gas6水平显著更高 (p<0.001).
- 在Gas6和母亲的BMI (r=0.774) 之间存在强烈的正相关性.
- 在Gas6和1小时OGTT葡萄糖水平之间存在中度正相关性 (r=0.577).
- 高Gas6水平与增加的出生体重和NICU入院有关.
结论:
- 升高的第二个三个月的母体血清Gas6可以作为GDM的早期预测生物标志物.
- 气体6可能表明患不良围产期并发症的风险增加.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Dipeptidyl Peptidase 4 Inhibitors
581
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
581


